Vasospasm
17
2
2
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
17.6%
3 terminated out of 17 trials
75.0%
-11.5% vs benchmark
12%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage
Vascular Lab Resource (VLR) Biorepository
Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury
Transcriptomic Signature of Vasospasm Consecutive to Sub-arachnoid Aneurismal Hemorrhage
Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
Transcranial Doppler Using Wearable Ultrasound Patch
Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients
Comparing the Nautilus NeuroWaveTM to TCD or DSA for the Detection of Vasospasm
Cerebral Autoregulation and Vasospasm in Patients With TBI
Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm
Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage
Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage
Balloon Prophylaxis of Aneurysmal Vasospasm
An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm
Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage
A Registry Study of Shuxuening Injection Used in Hospitals in China